The Family Rhabdoviridae: Mono- and Bipartite Negative-Sense RNA Viruses with Diverse Genome Organization and Common Evolutionary Origins
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Entwicklung Einer Software Zur Identifizierung Neuartiger Und
Entwicklung einer Software zur Identifizierung neuartiger und bekannter Infektionserreger in klinischen Proben Dissertation zur Erlangung des Doktorgrades an der Fakult¨at fur¨ Mathematik, Informatik und Naturwissenschaften Fachbereich Biologie der Universit¨at Hamburg vorgelegt von Malik Alawi Hamburg, 2020 Vorsitzender der Prufungskommission¨ Dr. PD Andreas Pommerening-R¨oser Gutachter Professor Dr. Adam Grundhoff Professor Dr. Stefan Kurtz Datum der Disputation 30. April 2021 Abstract Sequencing of diagnostic samples is widely considered a key technology that may fun- damentally improve infectious disease diagnostics. The approach can not only identify pathogens already known to cause a specific disease, but may also detect pathogens that have not been previously attributed to this disease, as well as completely new, previously unknown pathogens. Therefore, it may significantly increase the level of preparedness for future outbreaks of emerging pathogens. This study describes the development and application of methods for the identification of pathogenic agents in diagnostic samples. The methods have been successfully applied multiple times under clinical conditions. The corresponding results have been published within the scope of this thesis. Finally, the methods were made available to the scientific community as an open source bioinformatics tool. The novel software was validated by conventional diagnostic methods and it was compared to established analysis pipelines using authentic clinical samples. It is able to identify pathogens from different diagnostic entities and often classifies viral agents down to strain level. Furthermore, the method is capable of assembling complete viral genomes, even from samples containing multiple closely related viral strains of the same viral family. In addition to an improved method for taxonomic classification, the software offers functionality which is not present in established analysis pipelines. -
Using Cell Lines to Study Factors Affecting Transmission of Fish Viruses
Using cell lines to study factors affecting transmission of fish viruses by Phuc Hoang Pham A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in Biology Waterloo, Ontario, Canada, 2014 ©Phuc Hoang Pham 2014 AUTHOR'S DECLARATION I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii ABSTRACT Factors that can influence the transmission of aquatic viruses in fish production facilities and natural environment are the immune defense of host species, the ability of viruses to infect host cells, and the environmental persistence of viruses. In this thesis, fish cell lines were used to study different aspects of these factors. Five viruses were used in this study: viral hemorrhagic septicemia virus (VHSV) from the Rhabdoviridae family; chum salmon reovirus (CSV) from the Reoviridae family; infectious pancreatic necrosis virus (IPNV) from the Birnaviridae family; and grouper iridovirus (GIV) and frog virus-3 (FV3) from the Iridoviridae family. The first factor affecting the transmission of fish viruses examined in this thesis is the immune defense of host species. In this work, infections of marine VHSV-IVa and freshwater VHSV-IVb were studied in two rainbow trout cell lines, RTgill-W1 from the gill epithelium, and RTS11 from spleen macrophages. RTgill-W1 produced infectious progeny of both VHSV-IVa and -IVb. However, VHSV-IVa was more infectious than IVb toward RTgill-W1: IVa caused cytopathic effects (CPE) at a lower viral titre, elicited CPE earlier, and yielded higher titres. -
A Preliminary Study of Viral Metagenomics of French Bat Species in Contact with Humans: Identification of New Mammalian Viruses
A preliminary study of viral metagenomics of French bat species in contact with humans: identification of new mammalian viruses. Laurent Dacheux, Minerva Cervantes-Gonzalez, Ghislaine Guigon, Jean-Michel Thiberge, Mathias Vandenbogaert, Corinne Maufrais, Valérie Caro, Hervé Bourhy To cite this version: Laurent Dacheux, Minerva Cervantes-Gonzalez, Ghislaine Guigon, Jean-Michel Thiberge, Mathias Vandenbogaert, et al.. A preliminary study of viral metagenomics of French bat species in contact with humans: identification of new mammalian viruses.. PLoS ONE, Public Library of Science, 2014, 9 (1), pp.e87194. 10.1371/journal.pone.0087194.s006. pasteur-01430485 HAL Id: pasteur-01430485 https://hal-pasteur.archives-ouvertes.fr/pasteur-01430485 Submitted on 9 Jan 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License A Preliminary Study of Viral Metagenomics of French Bat Species in Contact with Humans: Identification of New Mammalian Viruses Laurent Dacheux1*, Minerva Cervantes-Gonzalez1, -
Virus Replication
Introduction • Encompasses > 150 viruses Rhabdoviridae •Rabies –only important human Brian Wells pathogen • One of the most lethal of all infectious diseases History History • Adapted from Latin meaning “to rage” • 1885 – Louis Pasteur – rabies vaccine • Greeks – lyssa – “frenzy” – Attenuated form of virus produced by inoculation of rabbit spinal cord • Rabies represents one of the oldest and most feared diseases • Occurs throughout the world except in Australia, Japan, Great Britain, • Recognized in Egypt before 2300 B.C. and islands such as Hawaii • Well described by Aristotle • “Reportable” disease • Iliad – “canine madness” Taxonomy Viral Structure • 3 Genera – Ephemerovirus, Lyssavirus, • 170 nm x 70 nm Vesiculovirus • Bullet-shaped enveloped virion • Infect vertebrates, invertebrates, and – Glycoprotein peplomers & matrix protein plants under envelope • Genus Lyssavirus comprises rabies • Helical symmetry virus and 3 rabies-like viruses • Linear minus sense ssRNA – 11-12 kb • Each capable of causing rabies-like • Glycoprotein spikes in outer membrane disease in humans bilayer 1 Virus Replication • Receptor-mediated endocytosis • Uncoat and release nucleocapsid into cytoplasm • Production of 5 monocistronic mRNA species - N, P (NS), M, G, L – by L+P viral transcriptase • Each mRNA capped and poly-A’ed • dsRNA replicative intermediate Virus Replication Virus Replication • N+P+L and (-) ssRNA form core • M forms matrix around core • Virus buds from glycoprotein area of plasma membrane and thus acquires its envelope Transmission • Unstable -
A Novel Rhabdovirus Infecting Newly Discovered Nycteribiid Bat Flies
www.nature.com/scientificreports OPEN Kanyawara Virus: A Novel Rhabdovirus Infecting Newly Discovered Nycteribiid Bat Flies Received: 19 April 2017 Accepted: 25 May 2017 Infesting Previously Unknown Published: xx xx xxxx Pteropodid Bats in Uganda Tony L. Goldberg 1,2,3, Andrew J. Bennett1, Robert Kityo3, Jens H. Kuhn4 & Colin A. Chapman3,5 Bats are natural reservoir hosts of highly virulent pathogens such as Marburg virus, Nipah virus, and SARS coronavirus. However, little is known about the role of bat ectoparasites in transmitting and maintaining such viruses. The intricate relationship between bats and their ectoparasites suggests that ectoparasites might serve as viral vectors, but evidence to date is scant. Bat flies, in particular, are highly specialized obligate hematophagous ectoparasites that incidentally bite humans. Using next- generation sequencing, we discovered a novel ledantevirus (mononegaviral family Rhabdoviridae, genus Ledantevirus) in nycteribiid bat flies infesting pteropodid bats in western Uganda. Mitochondrial DNA analyses revealed that both the bat flies and their bat hosts belong to putative new species. The coding-complete genome of the new virus, named Kanyawara virus (KYAV), is only distantly related to that of its closest known relative, Mount Elgon bat virus, and was found at high titers in bat flies but not in blood or on mucosal surfaces of host bats. Viral genome analysis indicates unusually low CpG dinucleotide depletion in KYAV compared to other ledanteviruses and rhabdovirus groups, with KYAV displaying values similar to rhabdoviruses of arthropods. Our findings highlight the possibility of a yet- to-be-discovered diversity of potentially pathogenic viruses in bat ectoparasites. Bats (order Chiroptera) represent the second largest order of mammals after rodents (order Rodentia). -
ERV) on Cell Culture
Downloaded from orbit.dtu.dk on: Nov 08, 2017 Characterization of eelpout rhabdovirus (ERV) on cell culture Blomkvist, E.; Alfjorden, A.; Hakhverdyan, Mikhayil; Boutrup, Torsten Snogdal; Ahola, H.; Ljunghager, F.; Hagström, Å.; Olesen, Niels Jørgen; Juremalm, M.; Leijon, M.; Valarcher, J.-F.; Axen, C. Published in: 17th International Conference on Diseases of Fish And Shellfish Publication date: 2015 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Blomkvist, E., Alfjorden, A., Hakhverdyan, M., Boutrup, T. S., Ahola, H., Ljunghager, F., ... Axen, C. (2015). Characterization of eelpout rhabdovirus (ERV) on cell culture. In 17th International Conference on Diseases of Fish And Shellfish: Abstract book (pp. 228-228). [P-004] Las Palmas: European Association of Fish Pathologists. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. DISCLAIMER: The organizer takes no responsibility for any of the content stated in the abstracts. -
Common COVID-19 Myths and Misinformation
Common COVID-19 Myths and Misinformation Myth: The side effects of Myth: The COVID-19 Myth: If I’ve already had the COVID-19 vaccine are vaccine can affect COVID-19, I don’t need a dangerous. women’s fertility. vaccine. Myth: Researchers rushed the development of the Myth: Getting the COVID- Myth: The COVID-19 COVID-19 vaccine, so its 19 vaccine gives you vaccine can affect effectiveness and safety COVID-19. women’s fertility. cannot be trusted. Myth: The COVID-19 vaccine enters your cells and changes your DNA. Information gathered from the following website: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/covid-19-vaccines-myth-versus-fact https://www.muhealth.org/our-stories/covid-19-vaccine-myths-vs-facts FACT: People who have gotten sick with COVID-19 may still benefit from getting vaccinated. Due to the severe health risks associated with COVID-19 and the fact that re-infection with COVID-19 is possible, people may be advised to get a COVID-19 vaccine If I’ve already had even if they have been sick with COVID-19 before. There is not enough information currently available to COVID-19, I don’t say if or for how long people are protected from getting COVID-19 after they have had it (natural need a vaccine. immunity). Early evidence suggests natural immunity from COVID-19 may not last very long, but more studies are needed to better understand this. Several subjects in the Pfizer trial who were previously infected got vaccinated without ill effects. Some scientists believe the vaccine offers better protection for coronavirus than natural infection. -
2020 Taxonomic Update for Phylum Negarnaviricota (Riboviria: Orthornavirae), Including the Large Orders Bunyavirales and Mononegavirales
Archives of Virology https://doi.org/10.1007/s00705-020-04731-2 VIROLOGY DIVISION NEWS 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales Jens H. Kuhn1 · Scott Adkins2 · Daniela Alioto3 · Sergey V. Alkhovsky4 · Gaya K. Amarasinghe5 · Simon J. Anthony6,7 · Tatjana Avšič‑Županc8 · María A. Ayllón9,10 · Justin Bahl11 · Anne Balkema‑Buschmann12 · Matthew J. Ballinger13 · Tomáš Bartonička14 · Christopher Basler15 · Sina Bavari16 · Martin Beer17 · Dennis A. Bente18 · Éric Bergeron19 · Brian H. Bird20 · Carol Blair21 · Kim R. Blasdell22 · Steven B. Bradfute23 · Rachel Breyta24 · Thomas Briese25 · Paul A. Brown26 · Ursula J. Buchholz27 · Michael J. Buchmeier28 · Alexander Bukreyev18,29 · Felicity Burt30 · Nihal Buzkan31 · Charles H. Calisher32 · Mengji Cao33,34 · Inmaculada Casas35 · John Chamberlain36 · Kartik Chandran37 · Rémi N. Charrel38 · Biao Chen39 · Michela Chiumenti40 · Il‑Ryong Choi41 · J. Christopher S. Clegg42 · Ian Crozier43 · John V. da Graça44 · Elena Dal Bó45 · Alberto M. R. Dávila46 · Juan Carlos de la Torre47 · Xavier de Lamballerie38 · Rik L. de Swart48 · Patrick L. Di Bello49 · Nicholas Di Paola50 · Francesco Di Serio40 · Ralf G. Dietzgen51 · Michele Digiaro52 · Valerian V. Dolja53 · Olga Dolnik54 · Michael A. Drebot55 · Jan Felix Drexler56 · Ralf Dürrwald57 · Lucie Dufkova58 · William G. Dundon59 · W. Paul Duprex60 · John M. Dye50 · Andrew J. Easton61 · Hideki Ebihara62 · Toufc Elbeaino63 · Koray Ergünay64 · Jorlan Fernandes195 · Anthony R. Fooks65 · Pierre B. H. Formenty66 · Leonie F. Forth17 · Ron A. M. Fouchier48 · Juliana Freitas‑Astúa67 · Selma Gago‑Zachert68,69 · George Fú Gāo70 · María Laura García71 · Adolfo García‑Sastre72 · Aura R. Garrison50 · Aiah Gbakima73 · Tracey Goldstein74 · Jean‑Paul J. Gonzalez75,76 · Anthony Grifths77 · Martin H. Groschup12 · Stephan Günther78 · Alexandro Guterres195 · Roy A. -
Characterization of Farmington Virus, a Novel Virus from Birds That Is Distantly Related to Members of the Family Rhabdoviridae
Palacios et al. Virology Journal 2013, 10:219 http://www.virologyj.com/content/10/1/219 RESEARCH Open Access Characterization of Farmington virus, a novel virus from birds that is distantly related to members of the family Rhabdoviridae Gustavo Palacios1†, Naomi L Forrester2,3,4†, Nazir Savji5,7†, Amelia P A Travassos da Rosa2, Hilda Guzman2, Kelly DeToy5, Vsevolod L Popov2,4, Peter J Walker6, W Ian Lipkin5, Nikos Vasilakis2,3,4 and Robert B Tesh2,4* Abstract Background: Farmington virus (FARV) is a rhabdovirus that was isolated from a wild bird during an outbreak of epizootic eastern equine encephalitis on a pheasant farm in Connecticut, USA. Findings: Analysis of the nearly complete genome sequence of the prototype CT AN 114 strain indicates that it encodes the five canonical rhabdovirus structural proteins (N, P, M, G and L) with alternative ORFs (> 180 nt) in the N and G genes. Phenotypic and genetic characterization of FARV has confirmed that it is a novel rhabdovirus and probably represents a new species within the family Rhabdoviridae. Conclusions: In sum, our analysis indicates that FARV represents a new species within the family Rhabdoviridae. Keywords: Farmington virus (FARV), Family Rhabdoviridae, Next generation sequencing, Phylogeny Background Results Therhabdovirusesarealargeanddiversegroupofsingle- Growth characteristics stranded, negative sense RNA viruses that infect a wide Three litters of newborn (1–2 day old) ICR mice with aver- range of vertebrates, invertebrates and plants [1]. The family agesizeof10pupswereinoculated intracerebrally (ic) with Rhabdoviridae is currently divided into nine approved ge- 15–20 μl, intraperitoneally (ip) with 100 μlorsubcutane- nera (Vesiculovirus, Perhavirus, Ephemerovirus, Lyssavirus, ously (sc) with 100 μlofastockofVero-grownFARV(CT Tibrovirus, Sigmavirus, Nucleorhabdovirus, Cytorhabdovirus AN 114) virus containing approximately 107 plaque and Novirhabdovirus);however,alargenumberofanimal forming units (PFU) per ml. -
Update on Approved and Candidate COVID-19 Vaccines in the EU
Update on approved and candidate COVID-19 vaccines in the EU Dr. Marco Cavaleri Head of Biological Health Threats and Vaccines Strategy, EMA An agency of the European Union Outline 1 EMA response to COVID-19 pandemic - milestones 2 COVID-19 vaccines approved in the EU 3 Benefits and risks of COVID-19 vaccines 4 Real world evidence on effectiveness 5 Studies in children 6 Vaccines under review by EMA 7 Adapting COVID-19 vaccines to variants 8 Additional information Classified as public by the European Medicines Agency EMA RESPONSE TO COVID-19 PANDEMIC Milestones in the fight against the pandemic Scientific & regulatory Rapid development & Transparency & mobilisation evaluation outreach Approval: Comirnaty, COVID-19 vaccine Moderna, COVID-19 vaccine AstraZeneca, COVID-19 vaccine Janssen Accelerated development & evaluation procedures WHO declares pandemic COVID-19 Experts’ Task Force Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2020 2021 1 Classified as public by the European Medicines Agency COVID-19 vaccines approved in the EU 4 vaccines authorised in the EU • Comirnaty and Moderna vaccines contain a molecule called messenger RNA (mRNA) with instructions for producing the spike protein from SARS-CoV-2, the virus that causes COVID-19 • The AstraZeneca and Janssen vaccine uses a non-replicating adenovirus as a carrier that has been modified to produce the spike protein from SARS-CoV-2. • The vaccines do not contain the SARS-CoV-2 virus causing COVID-19 itself and cannot cause the disease. Comirnaty COVID-19 Vaccine COVID-19 Vaccine COVID-19 Vaccine (BioNTech/Pfizer) Moderna AstraZeneca Janssen 21 Dec 6 Jan 29 Jan 11 Mar 2 Classified as public by the European Medicines Agency BENEFITS AND RISKS Efficacy of COVID-19 vaccines in trials All COVID-19 vaccines approved in the EU have a positive benefit-risk balance in prevention of COVID-19 disease. -
Attenuation of Human Respiratory Syncytial Virus by Genome-Scale Codon-Pair Deoptimization
Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization Cyril Le Nouëna,1, Linda G. Brocka, Cindy Luongoa, Thomas McCartya, Lijuan Yanga, Masfique Mehedia, Eckard Wimmerb,1, Steffen Muellerb,2, Peter L. Collinsa, Ursula J. Buchholza,3, and Joshua M. DiNapolia,3,4 aRNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and bDepartment of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794 Contributed by Eckard Wimmer, June 18, 2014 (sent for review February 14, 2014) Human respiratory syncytial virus (RSV) is the most important viral acid coding is unaffected, CPD strains provide the same reper- agent of serious pediatric respiratory-tract disease worldwide. A toire of epitopes for inducing cellular and humoral immunity as vaccine or generally effective antiviral drug is not yet available. the WT pathogen. Recently, the CPD approach has been used We designed new live attenuated RSV vaccine candidates by successfully to attenuate poliovirus, influenza A virus, Strepto- codon-pair deoptimization (CPD). Specifically, viral ORFs were recoded coccus pneumonia, and HIV type 1 (5, 10–13). by rearranging existing synonymous codons to increase the content In the present work, four CPD RSV genomes were designed, of underrepresented codon pairs. Amino acid coding was com- synthesized, and recovered by reverse genetics. The CPD pletely unchanged. Four CPD RSV genomes were designed in recombinant (r) RSVs were attenuated and temperature- which the indicated ORFs were recoded: Min A (NS1, NS2, N, P, sensitive in vitro. Furthermore, we demonstrated that the CPD M, and SH), Min B (G and F), Min L (L), and Min FLC (all ORFs except rRSVs were attenuated and immunogenic in mice and African M2-1 and M2-2). -
Comparison of Plant‐Adapted Rhabdovirus Protein Localization and Interactions
University of Kentucky UKnowledge University of Kentucky Doctoral Dissertations Graduate School 2011 COMPARISON OF PLANT‐ADAPTED RHABDOVIRUS PROTEIN LOCALIZATION AND INTERACTIONS Kathleen Marie Martin University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Martin, Kathleen Marie, "COMPARISON OF PLANT‐ADAPTED RHABDOVIRUS PROTEIN LOCALIZATION AND INTERACTIONS" (2011). University of Kentucky Doctoral Dissertations. 172. https://uknowledge.uky.edu/gradschool_diss/172 This Dissertation is brought to you for free and open access by the Graduate School at UKnowledge. It has been accepted for inclusion in University of Kentucky Doctoral Dissertations by an authorized administrator of UKnowledge. For more information, please contact [email protected]. ABSTRACT OF DISSERTATION Kathleen Marie Martin The Graduate School University of Kentucky 2011 COMPARISON OF PLANT‐ADAPTED RHABDOVIRUS PROTEIN LOCALIZATION AND INTERACTIONS ABSTRACT OF DISSERTATION A dissertation submitted in partial fulfillment of the requirements for the Degree of Doctor of Philosophy in the College of Agriculture at the University of Kentucky By Kathleen Marie Martin Lexington, Kentucky Director: Dr. Michael M Goodin, Associate Professor of Plant Pathology Lexington, Kentucky 2011 Copyright © Kathleen Marie Martin 2011 ABSTRACT OF DISSERTATION COMPARISON OF PLANT‐ADAPTED RHABDOVIRUS PROTEIN LOCALIZATION AND INTERACTIONS Sonchus yellow net virus (SYNV), Potato yellow dwarf virus (PYDV) and Lettuce Necrotic yellows virus (LNYV) are members of the Rhabdoviridae family that infect plants. SYNV and PYDV are Nucleorhabdoviruses that replicate in the nuclei of infected cells and LNYV is a Cytorhabdovirus that replicates in the cytoplasm. LNYV and SYNV share a similar genome organization with a gene order of Nucleoprotein (N), Phosphoprotein (P), putative movement protein (Mv), Matrix protein (M), Glycoprotein (G) and Polymerase protein (L).